FindTrial
Sign In

Analysis of the related factors of different subcutaneous injection techniques affecting the pain at the injection site of trastuzumab in breast cancer

Analysis of the related factors of different subcutaneous injection techniques affecting the pain at the injection site of trastuzumab in breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123874
Enrollment
Unknown
Registered
2026-04-30
Start date
2024-11-03
Completion date
Unknown
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain at the injection site

Interventions

Spiral group:None
Vertical group:None

Sponsors

Meishan City Peoples Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with HER-2 positive I-III stage breast cancer; 2. Patients aged between 18 and 75 years old; 3. Patients with a certain level of education, no language cognitive barriers, and good communication skills; 4. Patients with good compliance, actively cooperating with treatment and nursing; 5. Volunteers who are willing to participate in this study and understand the content of the research, signing an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Male breast cancer; 2. Patients with sensory dysfunction at the injection site; 3. Patients with consciousness disorders or mental disorders, unable to understand the study content or unable to comply with the study protocol; 4. Conditions deemed inappropriate by the investigator.

Design outcomes

Primary

MeasureTime frame
VisuaAnalogueScale;—

Countries

China

Contacts

Public ContactLudan Xu

Meishan City Peoples Hospital

275950301@qq.com+86 28 3802 5181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 7, 2026